Metronomic chemotherapy transitioned from the bench to bedside in the early 2000s and
since then has carved a niche for itself in pediatric oncology. It has been used solely or in …

Metronomic chemotherapy (MC) is the frequent, regular administration of drug doses
designed to maintain a low, but active, range of concentrations of chemotherapeutic drugs …

Despite intensive research in the field of cancer, many pediatric cancers are still incurable
with current treatment protocols. Repetitive administration of conventional chemotherapy at …

Background Metronomic chemotherapy (MC) is defined as the frequent administration of
chemotherapy at doses below the maximal tolerated dose and with no prolonged drug-free …

Metronomic chemotherapy, which is defined by the frequent, repetitive administration of
chemotherapeutic drugs at relatively low doses, and without prolonged drug-free break, is …

PURPOSE Low-and middle-income countries (LMICs) experience the burden of 80% of new
childhood cancer cases worldwide, with cure rates as low as 10% in some countries …

Angiogenesis is crucial for the growth of cancer. As such, it has become an established
target in fighting cancer. Metronomic chemotherapy-the chronic administration of …

Background In low‐and middle‐income countries, therapeutic options for advanced,
refractory, or relapsing malignancies are limited due to local constraints such as cost of …

Pediatric cancer has a better outcome profile than adult cancers. However, refractory
disease and the potential for long-term morbidity resulting from the use of conventional …

Background Metronomic chemotherapy (MC) is defined as the frequent administration of
chemotherapy at doses below the maximal tolerated dose and with no prolonged drug-free …